Bifunctional up-converting lanthanide nanoparticles for selective in vitro imaging and inhibition of cyclin D as anti-cancer agents.

Inhibition of the CDK4/cyclin D complex through the substrate recruitment site on the cyclin positive regulatory subunit is recognised as being a promising anti-cancer target. Specific peptide sequences can be used to selectively disrupt this target, but the development of peptides as anti-tumor agents in vitro/in vivo presents several obstacles. Poor cell internalization, low sensitivity towards enzymatic degradation in vivo, and ineffectiveness in monitoring via indirect screening are all issues which must be overcome. Herein, we describe the surface functionalization of lanthanide nanoparticles with cyclin D-specific peptides to prepare novel nanomaterials (UCNPs-P1) which can target the CDK4/cyclin D complex. The nanomaterials prepared (UCNPs-P1) are cell permeable and they display parallel emission spectra in vitro and in an aqueous biological environment. They can also be used in low dose concentrations under harmless NIR excitation and emission via upconversion. Uniquely, in addition to acting as a bioimaging probe, UCNPs-P1 also exhibits promising cytotoxicity towards cancer cells. In light of the aforementioned properties, the prepared functionalized nanomaterials (UCNPs-P1) offer the first real dual acting system for cyclin D imaging and simultaneous inhibition of cancer cell division.

[1]  A. Speghini,et al.  Europium (III) complexes with new N-donor ligand: A comparative study in solid state and solution , 2013 .

[2]  Svetlana V. Eliseeva,et al.  Intriguing aspects of lanthanide luminescence , 2013 .

[3]  Jianhua Hao,et al.  In vitro cell imaging using multifunctional small sized KGdF4:Yb3+,Er3+ upconverting nanoparticles synthesized by a one-pot solvothermal process. , 2013, Nanoscale.

[4]  M. Vázquez,et al.  A folding-based approach for the luminescent detection of a short RNA hairpin. , 2013, Journal of the American Chemical Society.

[5]  D. Parker,et al.  Anion binding in water at lanthanide centres: from structure and selectivity to signalling and sensing. , 2013, Chemical Society reviews.

[6]  P. Jallepalli,et al.  Enabling and disabling polo-like kinase 1 inhibition through chemical genetics. , 2012, ACS chemical biology.

[7]  T. Gunnlaugsson,et al.  Luminescent lanthanide-binding peptides: sensitising the excited states of Eu(III) and Tb(III) with a 1,8-naphthalimide-based antenna. , 2012, Organic & biomolecular chemistry.

[8]  H. Tam,et al.  Two-photon induced responsive f-f emissive detection of Cyclin A with a europium-chelating peptide. , 2011, Chemical communications.

[9]  F. Pentimalli,et al.  Peptides or small molecules? Different approaches to develop more effective CDK inhibitors. , 2011, Current medicinal chemistry.

[10]  G. Wood,et al.  Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis , 2011, Cell cycle.

[11]  J. Birchler.  RNA Interference: What is it? , 2010 .

[12]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[13]  Taeghwan Hyeon,et al.  Nonblinking and Nonbleaching Upconverting Nanoparticles as an Optical Imaging Nanoprobe and T1 Magnetic Resonance Imaging Contrast Agent , 2009 .

[14]  T. Park,et al.  siRNA delivery systems for cancer treatment. , 2009, Advanced drug delivery reviews.

[15]  A. Vidal,et al.  Cyclin A probes by means of intermolecular sensitization of terbium-chelating peptides. , 2008, Journal of the American Chemical Society.

[16]  V. J. Licata,et al.  Applications of fluorescence anisotropy to the study of protein-DNA interactions. , 2008, Methods in cell biology.

[17]  Ü. Langel,et al.  Assessing the delivery efficacy and internalization route of cell-penetrating peptides , 2007, Nature Protocols.

[18]  P. Fischer,et al.  REPLACE: A Strategy for Iterative Design of Cyclin‐Binding Groove Inhibitors , 2006, Chembiochem : a European journal of chemical biology.

[19]  Feng Wang,et al.  Synthesis of polyethylenimine/NaYF4 nanoparticles with upconversion fluorescence , 2006 .

[20]  Takahiro Ochiya,et al.  Therapeutic potential of RNA interference against cancer , 2006, Cancer science.

[21]  P. Nielsen,et al.  Enhanced delivery of cell-penetrating peptide–peptide nucleic acid conjugates by endosomal disruption , 2006, Nature Protocols.

[22]  Matthew S. Tremblay,et al.  Phosphorylation state-responsive lanthanide peptide conjugates: a luminescence switch based on reversible complex reorganization. , 2006, Organic letters.

[23]  Y. Urano,et al.  Modulation of luminescence intensity of lanthanide complexes by photoinduced electron transfer and its application to a long-lived protease probe. , 2006, Journal of the American Chemical Society.

[24]  M. Barbacid,et al.  Is Cyclin D1-CDK4 kinase a bona fide cancer target? , 2006, Cancer cell.

[25]  Tiansen Li,et al.  Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. , 2006, Cancer cell.

[26]  R. Hartmann,et al.  RNA interference as a gene-specific approach for molecular medicine. , 2005, Current medicinal chemistry.

[27]  S. Rane,et al.  Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis. , 2005, Cancer research.

[28]  D. Lane,et al.  Insights into cyclin groove recognition: complex crystal structures and inhibitor design through ligand exchange. , 2003, Structure.

[29]  A. Senderowicz.  Cell cycle modulators for the treatment of lung malignancies. , 2003, Clinical lung cancer.

[30]  D. Lane,et al.  Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunit. , 2003, Current medicinal chemistry. Anti-cancer agents.

[31]  D. Lane,et al.  Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A. , 2002, The journal of peptide research : official journal of the American Peptide Society.